Word

JOFILNY

Status

Pending

Status Code

661

Status Date

Wednesday, July 3, 2024

Serial Number

97860514

Mark Type

4

Filing Date

Tuesday, March 28, 2023

Trademark Owner History

Athira Pharma, Inc.

Classifications

5 : Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents; pharmaceuticals in the nature of small molecule chemical compounds; pharmaceuticals for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical agents for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis

Trademark Events

Mar 31, 2023

New Application Entered

Dec 21, 2023

Assigned To Examiner

Jan 8, 2024

Non-Final Action E-Mailed

Apr 4, 2023

New Application Office Supplied Data Entered

Jan 8, 2024

Non-Final Action Written

Jan 8, 2024

Notification Of Non-Final Action E-Mailed

Jan 26, 2024

Application Extension To Response Period - Received

Jan 26, 2024

Application Extension Granted/Receipt Provided

Jul 3, 2024

Teas/Email Correspondence Entered

Jul 3, 2024

Correspondence Received In Law Office

Jul 3, 2024

Teas Response To Office Action Received

Jul 16, 2024

Assigned To Examiner